The Ethical Standard for End-of-Life Decisions for Unrepresented Patients

Area of Science:

• Medical Ethics
• Bioethics
• Clinical Decision-Making

Background:

• Growing recognition of ethical and moral complexities in caring for unrepresented patients.
• Unrepresented patients lack decision-making capacity, surrogate decision-makers, and stated treatment preferences.
• Existing discourse primarily addresses procedural aspects of decision-making for these patients.

Purpose of the Study:

• To evaluate the ethical justification of different standards for end-of-life decisions for unrepresented patients.
• To compare the best interest standard with the medical futility standard.
• To determine which ethical standard offers superior justification for clinical practice.

Main Methods:

• Comparative analysis of two ethical standards: best interest and medical futility.
• Examination of arguments for and against each standard.
• Ethical evaluation of their applicability to end-of-life decisions.

Main Results:

• The best interest standard is conventional but less demanding.
• The medical futility standard is novel and more demanding.
• The medical futility standard is argued to be ethically superior.

Conclusions:

• The medical futility standard provides a more robust ethical framework for end-of-life decisions.
• The medical futility standard should supersede the best interest standard for unrepresented patients.
• This shift aims to improve ethical care and respect for patient values.